Johann Bartko

Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial

Ulrich Jäger, Shirley D’Sa, Christian Schörgenhofer et al. · Blood · 2018 · 110 citations · Full text

Medicine, Hematology, Immunology +17

Effect of ischemic preconditioning in skeletal muscle measured by functional magnetic resonance imaging and spectroscopy: a randomized crossover trial

Martin Andreas, A. Schmid, Mohammad Kéilani et al. · Journal of Cardiovascular Magnetic Resonance · 2011 · 98 citations · Full text

Life Sciences, Physiology, Biomedical Imaging +14

Increased platelet aggregation and in vivo platelet activation after granulocyte colony-stimulating factor administration

Alexander Spiel, Johann Bartko, Michael Schwameis et al. · Thrombosis and Haemostasis · 2011 · 65 citations

Medicine, Hematology, Immunology +16

Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Study of the Penetration of a Monoclonal Antibody Combination (ASN100) Targeting <i>Staphylococcus aureus</i> Cytotoxins in the Lung Epithelial Lining Fluid of Healthy Volunteers

Zoltán Magyarics, Fraser Leslie, Johann Bartko et al. · Antimicrobial Agents and Chemotherapy · 2019 · 61 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

A Randomized, First‐in‐Human, Healthy Volunteer Trial of sutimlimab, a Humanized Antibody for the Specific Inhibition of the Classical Complement Pathway

Johann Bartko, Christian Schoergenhofer, Michael Schwameis et al. · Clinical Pharmacology & Therapeutics · 2018 · 60 citations · Full text

Life Sciences, Immunology, Pharmacology +17